Skip to main content
Article

The reported impact of non-communicable disease investment cases in 13 countries

Giuseppe TroisiWHO Regional Office for the Eastern Mediterranean, Cairo, EgyptRoy SmallUnited Nations Development Programme, New York, New York, USARoman ChestnovInternational Telecommunication Union, Geneva, SwitzerlandDiana AndreasyanNational Institute of Health/National Health Information Analytic Center, Ministry of Health of the Republic of Armenia, Yerevan, ArmeniaHenrik KhachatryanWHO Armenia, Yerevan, ArmeniaE. PhillipsGovernment of Barbados Ministry of Health & Wellness, Saint Michael, BarbadosTaraleen MalcolmPan American Health Organization, Washington, District of Columbia, USAHero KolDepartment of Preventive Medicine, Royal Government of Cambodia Ministry of Health, Phnom Penh, CambodiaNargiza KhodjaevaMussie GebremichaelDisease Prevention and Control Directorate, Ethiopia Ministry of Health, Addis Ababa, EthiopiaAddisu Worku TessemaFederal Ministry of Health, Addis Ababa, EthiopiaAsmamaw Bezabeh WorknehWHO Country Office for Ethiopia, Addis Ababa, EthiopiaTamu DavidsonMinistry of Health and Wellness, Kingston, JamaicaMichelle A. HarrisPan American Health Organization, Washington, District of Columbia, USANurgul IbraevaAigul NurmatovaSmoke-free Universities, Bishkek, KyrgyzstanAliina AltymyshevaJohn Juliard GoWHO Philippines, Manila, PhilippinesА. V. KontsevayaNational Research Center for Preventive Medicine, Ministry of Health of the Russian Federation, Moskva, Russian FederationKrisada HanbunjerdGovernment of ThailandSushera BunluesinOlivia NieverasBanu EkıncıRepublic of Türkiye Ministry of Health, Cankaya, TürkiyeBekir KeskinkılıçRepublic of Türkiye Ministry of Health, Cankaya, TürkiyeToker ErgüderOyoo Charles AkiyaDepartment of NCDs, Republic of Uganda Ministry of Health, Kampala, UgandaHafisa KasuleWHO Country Office for Uganda, Kampala, UgandaAidah NakanjakoShukhrat ShukurovHealthy Lifestyle and Physical Activity Support Center, Ministry of Health of the Republic of Uzbekistan, Tashkent, UzbekistanNazokat KasymovaWHO Uzbekistan, Tashkent, UzbekistanPatrick BandaZambia Ministry of Health, Lusaka, ZambiaErnest KakomaZambia Ministry of Health, Lusaka, ZambiaNathan N. BakyaitaWHO, Lusaka, ZambiaAlexey KulikovDudley TarltonNadia PutoudThe Global Fund to Fight AIDS, Tuberculosis and Malaria, Grand-Saconnex, SwitzerlandScott ChiossiDouglas WebbUNDP, Tblisi, GeorgiaNick Banatvala
BMJ Global Healthjournal2024en
ABI

Abstract

Non-communicable diseases (NCDs) are a leading health and development challenge worldwide. Since 2015, WHO and the United Nations Development Programme have provided support to governments to develop national NCD investment cases to describe the socioeconomic dimensions of NCDs. To assess the impact of the investment cases, semistructured interviews and a structured process for gathering written feedback were conducted between July and October 2022 with key informants in 13 countries who had developed a national NCD investment case between 2015 and 2020. Investment cases describe: (1) the social and economic costs of NCDs, including their distribution and projections over time; (2) priority areas for scaled up action; (3) the cost and returns from investing in WHO-recommended measures to prevent and manage NCDs; and (4) the political dimensions of NCD responses. While no country had implemented all the recommendations set out in their investment case reports, actions and policy changes attributable to the investment cases were identified, across (1) governance; (2) financing; and (3) health service access and delivery. The pathways of these changes included: (1) stronger collaboration across government ministries and partners; (2) advocacy for NCD prevention and control; (3) grounding efforts in nationally owned data and evidence; (4) developing mutually embraced 'language' across health and finance; and (5) elevating the priority accorded to NCDs, by framing action as an investment rather than a cost. The assessment also identified barriers to progress on the investment case implementation, including the influence of some private sector entities on sectors other than health, the impact of the COVID-19 pandemic, and changes in senior political and technical government officials. The results suggest that national NCD investment cases can significantly contribute to catalysing the prevention and control of NCDs through strengthening governance, financing, and health service access and delivery.

Topics

Identifiers

Citations and references

Cited by 06 references